Scientists at the Indian Institute of Science (IISc), Bengaluru have developed a new diagnostic tool for early...Read more
A question was recently asked by the Science and Technology Minister Dr. Harsh Vardhan, stating that how much ...Read more
Eppendorf India, a wholly owned subsidiary of Eppendorf AG, recently announced the extension of the training c...Read more
US based medical technology firm Boston Scientific Corporation has recently appointed Warren Wang as its senio...Read more
The Virology Institute of Kerala which was proposed to be established by the Kerala Biotechnology Commission (...Read more
India to bounce back as Clinical Research Hub
India was considered as an all-time favoured destination for clinical trials. Most of the outsourced studies are phase III studies where India has a diverse pool of patients. After 2010 there was major setback in the CRO Industry in India. Drug Controller General of India (DCGI) approvals were delayed and multinational sponsors stepped back outsourcing studies to India. But slowly post 2016 DCGI has been generous enough in proving approvals and online application system has brought a lot of difference. Indian Clinical Trial market and clinical trial services is expected to grow significantly along with trends.